Immatics N.V. (IMTX)Healthcare | Biotechnology | Tübingen, Germany | NasdaqCM
11.25 USD
+11.25
(0.000%)
⇧
(April 20, 2026, 4 p.m.
EDT)
Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:41 p.m. EDT
The 'Strong Buy' analyst consensus is generating a dangerous rating inflation on IMTX; the market is rightly warning against value traps in a biosimilar company with -65% revenue growth and negative gross margins. Despite the shares being up significantly, the waterfall of Open Interest in OTM puts signals institutional capitulation or active de-spiking before a potential bankruptcy restructuring rather than a sustainable recover. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.029765 |
| AutoETS | 0.029777 |
| AutoARIMA | 0.029777 |
| MSTL | 0.030896 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 71% |
| H-stat | 0.87 |
| Ljung-Box p | 0.039 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 2.43 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 3.23 |
| Revenue per Share | 0.394 |
| Market Cap | 1,508,586,496 |
| Forward P/E | -6.34 |
| Beta | 1.34 |
| Website | https://www.immatics.com |
As of April 18, 2026, 10:41 p.m. EDT: Speculators are positioning defensively. Despite a 29.0% rise in the underlying price to $11.17, the Open Interest (OI) profile heavily favors downside protection. For the 2026-04-17 expiration, 100% of expiring volume in $9 and $10 strikes is concentrated in Puts, while $11.00 is the ATM anchor for Calls but gains little OI. Long-term puts ($7-$8 strikes) show high IV (5.0) relative to calls, indicating a heavy skew towards hedging rather than directional bullish speculation.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.6041667 |
| Address1 | Paul-Ehrlich-Strasse 15-19 |
| All Time High | 18.42 |
| All Time Low | 0.005 |
| Ask | 11.27 |
| Ask Size | 1 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 295,090 |
| Average Daily Volume3 Month | 447,263 |
| Average Volume | 447,263 |
| Average Volume10Days | 295,090 |
| Beta | 1.337 |
| Bid | 11.21 |
| Bid Size | 1 |
| Book Value | 4.260294 |
| City | Tübingen |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Germany |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 11.25 |
| Current Ratio | 11.718 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 11.29 |
| Day Low | 10.8 |
| Debt To Equity | 3.23 |
| Display Name | Immatics |
| Earnings Timestamp | 1,772,717,400 |
| Earnings Timestamp End | 1,778,070,600 |
| Earnings Timestamp Start | 1,778,070,600 |
| Ebitda | -172,875,008 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -6.102 |
| Enterprise To Revenue | 21.856 |
| Enterprise Value | 1,054,884,480 |
| Eps Current Year | -1.75 |
| Eps Forward | -1.77311 |
| Eps Trailing Twelve Months | -1.9 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 49 7071 5397 900 |
| Fifty Day Average | 10.0804 |
| Fifty Day Average Change | 1.1695995 |
| Fifty Day Average Change Percent | 0.11602709 |
| Fifty Two Week Change Percent | 160.41667 |
| Fifty Two Week High | 12.41 |
| Fifty Two Week High Change | -1.1599998 |
| Fifty Two Week High Change Percent | -0.093472995 |
| Fifty Two Week Low | 3.94 |
| Fifty Two Week Low Change | 7.31 |
| Fifty Two Week Low Change Percent | 1.8553299 |
| Fifty Two Week Range | 3.94 - 12.41 |
| Financial Currency | EUR |
| First Trade Date Milliseconds | 1,544,625,000,000 |
| Float Shares | 69,330,612 |
| Forward Eps | -1.77311 |
| Forward P E | -6.344784 |
| Free Cashflow | -128,190,248 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 589 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | -2.80873 |
| Gross Profits | -135,566,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.17918 |
| Held Percent Institutions | 0.76458 |
| Implied Shares Outstanding | 134,096,576 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes Anzu-cel (IMA203), a one-time infusion PRAME cell therapy, which is in Phase 2 trial; IMA203CD8, a cell therapy product that is in Phase 1 clinical trial; IMA204 that targets tumor stroma, which is in Phase 1 clinical trial; and Anzu-cel in combination with Moderna's PRAME cell therapy enhancer (mRNA-4203), which is in Phase 1 clinical trial. The company also develops TCR Bispecifics products, including IMA401 and IMA402, which is in Phase 1a clinical trial. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany. |
| Long Name | Immatics N.V. |
| Market | us_market |
| Market Cap | 1,508,586,496 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_8986547 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -196,447,008 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,507,245,514 |
| Number Of Analyst Opinions | 8 |
| Open | 11.09 |
| Operating Cashflow | -176,626,000 |
| Operating Margins | -1.9675599 |
| Payout Ratio | 0.0 |
| Phone | 49 7071 5397 0 |
| Pre Market Change | 0.23999977 |
| Pre Market Change Percent | 2.1333313 |
| Pre Market Price | 11.49 |
| Pre Market Time | 1,776,759,087 |
| Previous Close | 0.0 |
| Price Eps Current Year | -6.428571 |
| Price Hint | 2 |
| Price To Book | 2.640663 |
| Price To Sales Trailing12 Months | 31.255676 |
| Profit Margins | 0.0 |
| Quick Ratio | 11.072 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 11.25 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 11.29 |
| Regular Market Day Low | 10.8 |
| Regular Market Day Range | 10.8 - 11.29 |
| Regular Market Open | 11.09 |
| Regular Market Previous Close | 0.0 |
| Regular Market Price | 11.25 |
| Regular Market Time | 1,776,715,201 |
| Regular Market Volume | 260,141 |
| Return On Assets | -0.18079 |
| Return On Equity | -0.37103 |
| Revenue Growth | -0.649 |
| Revenue Per Share | 0.394 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 134,096,576 |
| Shares Percent Shares Out | 0.0385 |
| Shares Short | 5,165,069 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 5,160,792 |
| Short Name | Immatics N.V. |
| Short Percent Of Float | 0.0563 |
| Short Ratio | 8.54 |
| Source Interval | 15 |
| Symbol | IMTX |
| Target High Price | 25.0 |
| Target Low Price | 11.0 |
| Target Mean Price | 18.75 |
| Target Median Price | 18.0 |
| Total Cash | 469,336,992 |
| Total Cash Per Share | 3.5 |
| Total Debt | 15,635,000 |
| Total Revenue | 48,266,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | NaN |
| Trailing Eps | -1.9 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 8.826075 |
| Two Hundred Day Average Change | 2.4239254 |
| Two Hundred Day Average Change Percent | 0.27463233 |
| Type Disp | Equity |
| Volume | 260,141 |
| Website | https://www.immatics.com |
| Zip | 72,076 |